Developing Novel Carriers to Deliver Targeted Immunotoxins for the Treatment of Primary and Metastatic Non-Small Cell Lung Cancer

Loading...
Thumbnail Image
File version
Author(s)
Primary Supervisor

Wei, Ming

Other Supervisors

Wilson, Jennifer

Editor(s)
Date
2017
Size
File type(s)
Location
License
Abstract

Non-small cell lung cancer (NSCLC) accounts for 85% of lung cancer which is a leading cause of cancer death. Most patients (>80%) present with advanced NSCLC when curative surgery is no longer an option. Other conventional therapies, such as chemotherapy, radiotherapy and existing molecular targeted therapy have neither significantly extended the life span of most patients, nor improved their quality of life. This is not only because of the large tumor load in the advanced stage of NSCLC but its metastasis. This project devises a novel approach to shield the “magic bullet” and help it locate and kill targeted cancer cells.

Journal Title
Conference Title
Book Title
Edition
Volume
Issue
Thesis Type

Thesis (PhD Doctorate)

Degree Program

Doctor of Philosophy (PhD)

School

School of Medical Science

Publisher link
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement

The author owns the copyright in this thesis, unless stated otherwise.

Item Access Status
Note
Access the data
Related item(s)
Subject

Non-small cell lung cancer (NSCLC)

Tumor metastasis

Persistent link to this record
Citation